Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol-Myers Squibb discovers PD-1/PD-L1 interaction inhibitors

Oct. 18, 2018

New 5-HT2C receptor agonists described by AbbVie

Oct. 18, 2018

Novartis discloses protein atonal homolog 1 activators

Oct. 18, 2018

Pseudolysin inhibitors presented by Antabio SAS

Oct. 18, 2018

Beijing Jacobio Pharmaceuticals, Jacobio-Alpha Pharmaceuticals patent PTP2C inhibitors

Oct. 18, 2018

Merck & Co. discovers antimycobacterial oxazolidinones

Oct. 18, 2018

Aslan begins phase I study of ASLAN-004 for atopic dermatitis

Oct. 18, 2018

Hutchison China MediTech initiates phase I study in China with HMPL-523 for AML

Oct. 18, 2018

Transgene initiates phase I/II trial of TG-6002 in advanced gastrointestinal tumors

Oct. 18, 2018

GeNeuro gives update on pHERV-K antibody program for ALS

Oct. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.